At3g61360 Antibody

What is the At3g61360 Antibody and what protein does it target?

At3g61360 Antibody (product code CSB-PA885520XA01DOA) is a research-grade antibody that targets the Q9M2C8 protein in Arabidopsis thaliana (Mouse-ear cress) . This antibody is specifically designed to recognize and bind to protein products of the At3g61360 gene, which is found on chromosome 3 of the Arabidopsis genome. The antibody serves as a crucial tool for researchers investigating protein expression, localization, and function in plant cellular processes. When designing experiments with this antibody, researchers should consider specific validation steps to ensure proper binding and specificity for the target protein.

How should researchers validate the specificity of At3g61360 Antibody before experimental use?

Antibody specificity validation is a critical first step before incorporating At3g61360 Antibody into your experimental workflow. The primary validation approach should include testing against both positive controls (samples known to express the target protein) and negative controls (samples where the target protein is absent) . For At3g61360 Antibody, wild-type Arabidopsis thaliana tissue samples serve as positive controls, while knockout or knockdown lines for the At3g61360 gene function as appropriate negative controls.

According to established protocols, researchers should:

• Perform Western blot analysis to confirm binding at the expected molecular weight

• Use immunoprecipitation followed by mass spectrometry to verify target identity

• Test antibody performance in immunohistochemistry using fixation-optimized protocols

• Validate reactivity across various experimental conditions to ensure consistent performance

Remember that antibody specificity testing is not a one-time process but should be repeated periodically to monitor potential changes in antibody performance, especially when using different batches.

What are the recommended starting dilutions for At3g61360 Antibody in different applications?

The optimal working dilution for At3g61360 Antibody varies by application. Based on established antibody optimization protocols, researchers should begin with a titration series to determine the optimal concentration providing the highest signal-to-noise ratio. The titration process involves testing the antibody at multiple concentrations across a logarithmic scale .

Initial recommended dilutions for common applications include:

When optimizing, researchers should follow the antibody titration approach illustrated in Figure-2 of the reference material, which shows a systematic dilution series (0μl, 1.25μl, 2.5μl, 5μl, 7.5μl, and 20μl) to determine optimal antibody volume . The goal is to identify the concentration that provides at least a 1-decade log difference between positive and negative populations.

How can researchers address potential heterophilic antibody interference when using At3g61360 Antibody in plant-animal hybrid experimental systems?

Heterophilic antibody interference represents a significant challenge in experimental systems that combine plant extracts with mammalian-derived detection antibodies. Studies have shown that approximately 30% of samples containing heterophilic antibodies can produce false positive results in two-site immunoassays . When using At3g61360 Antibody (which may be derived from murine systems) to study Arabidopsis proteins in complex experimental designs, researchers should implement specific controls.

To mitigate heterophilic antibody interference:

• Include blocking reagents containing non-immune immunoglobulins from the same species as the antibody

• Pre-absorb samples with species-specific immunoglobulin

• Design sandwich assays with capture and detection antibodies from different species

• Validate results using alternative detection methods not relying on antibody binding

• Compare results with genetic approaches (knockout/knockdown lines) to confirm specificity

This interference occurs due to steric inhibition of target binding to complexed antibody. Research has demonstrated that heterophilic antibodies can bind immunoglobulins from multiple species, creating complex cross-reactivity patterns that affect experimental outcomes .

What strategies can be employed to optimize At3g61360 Antibody performance in multicolor flow cytometry experiments with plant cells?

Optimizing At3g61360 Antibody for multicolor flow cytometry with plant cells requires strategic planning to address plant-specific challenges. The optimization process should focus on four key factors: ensuring antigen specificity, determining optimal antibody volume for maximum signal-to-noise ratio, minimizing background fluorescence, and addressing potential steric hindrance issues .

When incorporating At3g61360 Antibody into a multicolor panel:

• Fluorochrome selection: Choose a fluorochrome compatible with plant cell autofluorescence profiles. For plant cell analysis, fluorochromes with emission peaks distant from chlorophyll autofluorescence (650-750nm) are preferred.

• Panel design assessment: Implement fluorescence minus one (FMO) controls to evaluate spillover between channels. Set up systematic testing tubes:

  • Unstained control (no antibody)

  • Single stain controls (each antibody alone)

  • Steric hindrance evaluation (comparing single vs. complete antibody set)

  • FMO controls (removing one antibody at a time)

• Steric hindrance testing: Compare the staining pattern of At3g61360 Antibody alone versus within the complete antibody cocktail. Acceptable performance requires less than 2% difference in percent positive cells and less than 0.1 log difference in fluorescence intensity, similar to the example shown in Figure-7 of the reference .

This systematic approach ensures that At3g61360 Antibody performs optimally within complex multicolor panels, even when analyzing challenging plant cell samples with high autofluorescence.

How can researchers identify structurally related antibodies to At3g61360 Antibody for cross-validation studies?

Identifying structurally related antibodies for cross-validation represents an advanced research approach. Rather than relying solely on sequence homology, researchers can employ structure-prediction scoring matrices to identify antibodies with similar binding properties despite different amino acid sequences .

To identify structurally related antibodies to At3g61360 Antibody:

• Implement position-specific structure-scoring matrix (P3SM) approaches incorporating Rosetta-derived structure-prediction scores

• Focus analysis on complementarity-determining regions (CDRs), particularly HCDR3, which is critical for antigen recognition

• Select candidate antibodies with predicted structural similarity rather than sequence similarity

• Validate candidates through recombinant expression and functional testing

Research has demonstrated that this approach can successfully identify functionally similar antibodies with different sequences. For example, in a study of influenza virus-specific antibodies, researchers identified HCDR3 loops with structural similarity to a reference antibody (CH65) despite sequence divergence. These structurally similar antibodies demonstrated comparable antigen binding and viral neutralization properties, as shown in this comparative data:

This approach can be applied to identify antibodies structurally similar to At3g61360 Antibody, providing valuable alternatives for experimental validation.

What considerations should guide the design of control experiments when using At3g61360 Antibody for protein localization studies?

Designing robust control experiments for protein localization studies with At3g61360 Antibody requires a comprehensive approach addressing both antibody performance and biological variability. Effective control strategies should include:

• Genetic controls: Test antibody in wild-type versus At3g61360 knockout/knockdown lines to confirm specificity. This genetic validation is particularly important for plant proteins where cross-reactivity is common.

• Peptide competition assays: Pre-incubate the antibody with excess purified target peptide before immunostaining to block specific binding sites. This approach differentiates between specific and non-specific binding patterns.

• Secondary antibody-only controls: Omit primary antibody (At3g61360 Antibody) while maintaining all other assay components to assess background from secondary detection systems.

• Tissue-specific expression validation: Compare antibody staining patterns with known transcript expression data from RNA-seq or microarray studies of the At3g61360 gene.

• Subcellular marker co-localization: Include established organelle markers alongside At3g61360 Antibody to confirm expected subcellular localization patterns .

These controls collectively provide multiple lines of evidence to validate antibody specificity and localization findings, critical for publications in high-impact journals where antibody validation is increasingly scrutinized.

How should researchers troubleshoot weak or inconsistent signals when using At3g61360 Antibody?

Troubleshooting weak or inconsistent signals with At3g61360 Antibody requires systematic evaluation of multiple experimental parameters. When signal strength is suboptimal, researchers should implement this structured problem-solving approach:

• Antibody titration reassessment: Perform a comprehensive titration series as illustrated in Figure-6 of the reference material, where antibody volumes are systematically varied while maintaining constant sample volume . The optimal antibody concentration should provide a signal-to-noise ratio of at least 10:1.

• Sample preparation optimization: For plant tissues containing the At3g61360 protein, evaluate:

  • Different extraction buffers (varying salt concentration, detergents, and pH)

  • Alternate fixation protocols (paraformaldehyde concentration and incubation time)

  • Antigen retrieval methods (heat-induced versus enzymatic)

  • Fresh versus frozen sample comparison

• Antibody binding conditions modification:

  • Incubation temperature (4°C, room temperature, 37°C)

  • Incubation duration (2 hours versus overnight)

  • Blocking agent composition (BSA, normal serum, commercial blockers)

  • Washing stringency and buffer composition

• Signal amplification approaches:

  • Implement biotin-streptavidin amplification systems

  • Use tyramide signal amplification for immunohistochemistry

  • Consider polymer-based detection systems for enhanced sensitivity

Each parameter should be modified independently while keeping others constant to identify the specific factors affecting signal quality. Document all optimization steps meticulously to ensure reproducibility once optimal conditions are established.

What strategies can minimize batch-to-batch variability when working with At3g61360 Antibody across long-term research projects?

Managing batch-to-batch variability is essential for research projects extending over multiple antibody lots. To ensure consistent performance of At3g61360 Antibody across extended research timelines, implement these strategic approaches:

• Reference standard establishment: Create and maintain an internal reference standard by:

  • Reserving a portion of the initial validated antibody lot as a benchmark

  • Preparing standardized positive control samples (protein extracts from wild-type Arabidopsis)

  • Documenting performance metrics (signal intensity, background levels, specific/non-specific binding ratios)

• Lot-to-lot validation protocol:

  • Implement side-by-side testing of new lots against the reference standard

  • Perform quantitative analysis of staining intensity and pattern recognition

  • Establish acceptance criteria (e.g., less than 10% variation in signal intensity)

  • Document validation results for each new lot in a laboratory information management system

• Long-term storage optimization:

  • Aliquot antibodies into single-use volumes to minimize freeze-thaw cycles

  • Store at -80°C for long-term preservation rather than -20°C

  • Include cryoprotectants (glycerol, BSA) to maintain antibody stability

  • Implement temperature monitoring systems for freezer storage

• Working dilution standardization:

  • Prepare master stocks at consistent concentrations

  • Standardize diluent composition to minimize matrix effects

  • Validate working dilution performance for each new application

This comprehensive approach ensures that experimental outcomes remain comparable throughout extended research timelines, critical for longitudinal studies and multi-year grant projects involving At3g61360 protein analysis.

How should researchers interpret cross-reactivity patterns when At3g61360 Antibody binds to multiple protein bands in Western blot analyses?

Cross-reactivity in Western blot analyses with At3g61360 Antibody requires careful interpretation to distinguish between specific and non-specific binding patterns. When multiple bands appear, researchers should systematically evaluate several possibilities:

• Post-translational modifications: The At3g61360 protein may exist in multiple forms due to:

  • Phosphorylation, glycosylation, or ubiquitination

  • Proteolytic processing yielding fragments of the full-length protein

  • Alternative splicing generating protein isoforms

• Antibody specificity assessment: Implement targeted experiments to determine band specificity:

  • Perform peptide competition assays using synthetic peptides matching the immunogen

  • Compare band patterns between wild-type and gene knockout/knockdown samples

  • Analyze mass spectrometry data of immunoprecipitated proteins to identify cross-reactive species

• Technical parameters optimization:

  • Adjust blocking conditions to reduce non-specific binding

  • Optimize washing stringency and detergent concentration

  • Verify sample preparation protocols to minimize protein degradation

• Quantitative analysis framework:

  • For each band, calculate the signal-to-noise ratio to distinguish specific from background signals

  • Compare band intensity patterns across biological replicates

  • Document molecular weight of each band precisely using appropriate protein standards

This systematic approach allows researchers to differentiate between true cross-reactivity (binding to related proteins), detection of protein variants, and non-specific background signals, enabling accurate interpretation of experimental results.

What statistical approaches are most appropriate for analyzing quantitative data from experiments using At3g61360 Antibody?

• For comparing expression levels across experimental conditions:

  • For normally distributed data: Apply Student's t-test (two groups) or ANOVA with post-hoc tests (multiple groups)

  • For non-normally distributed data: Use Mann-Whitney U test (two groups) or Kruskal-Wallis with Dunn's post-hoc test (multiple groups)

  • Include correction for multiple comparisons (Bonferroni or Benjamini-Hochberg) when analyzing multiple proteins or conditions

• For time-course experiments:

  • Implement repeated measures ANOVA to account for within-subject correlations

  • Consider mixed-effects models when dealing with missing data points

  • Apply area-under-curve analysis for cumulative response assessment

• For correlation with other biological parameters:

  • Use Pearson correlation for linear relationships with normally distributed data

  • Apply Spearman rank correlation for non-parametric or non-linear relationships

  • Implement multiple regression to assess contributions of different variables

• For image-based quantification:

  • Normalize signal intensity to account for background variation

  • Implement blind analysis to prevent observer bias

  • Use appropriate thresholding algorithms consistently across samples

• Power analysis considerations:

  • Calculate minimum sample size needed based on preliminary data variability

  • Report effect sizes alongside p-values to indicate biological significance

  • Establish a priori significance thresholds and adhere to them during analysis

These statistical approaches ensure that quantitative differences in At3g61360 protein expression or localization are analyzed with appropriate rigor, enhancing the reproducibility and validity of research findings.

How can researchers integrate At3g61360 Antibody data with transcriptomic and proteomic datasets for comprehensive functional analysis?

Integrating antibody-based protein detection data with transcriptomic and proteomic datasets provides a multidimensional understanding of At3g61360 function. This integrative approach reveals relationships between gene expression, protein abundance, and functional outcomes through these methodological steps:

• Multi-omics data correlation framework:

  • Compare protein levels (detected by At3g61360 Antibody) with mRNA expression from RNA-seq

  • Calculate protein-to-mRNA ratios to identify post-transcriptional regulation

  • Align protein expression patterns with interactome data from mass spectrometry studies

  • Integrate with phosphoproteomics data to associate protein abundance with activation status

• Time-resolved analysis approaches:

  • Implement time-course experiments to detect temporal relationships between transcription and translation

  • Apply time-lag correlation methods to account for delays between mRNA expression and protein accumulation

  • Use mathematical modeling to infer regulatory relationships from temporal patterns

• Network analysis methodologies:

  • Construct protein-protein interaction networks centered on At3g61360

  • Implement pathway enrichment analysis to identify biological processes

  • Apply gene set enrichment analysis (GSEA) to connect protein expression with functional pathways

  • Utilize weighted gene co-expression network analysis (WGCNA) to identify co-regulated modules

• Data integration tools:

  • Cytoscape for network visualization and analysis

  • R/Bioconductor packages for statistical integration of multi-omics data

  • Machine learning approaches to identify patterns across datasets

  • Dimensionality reduction techniques (PCA, t-SNE) to visualize relationships

This integrated approach transforms single-protein antibody data into comprehensive insights about At3g61360's role within cellular networks and biological processes, enhancing the impact and utility of antibody-based research findings.

How can At3g61360 Antibody be adapted for super-resolution microscopy applications in plant cell research?

Adapting At3g61360 Antibody for super-resolution microscopy enables visualization of protein localization at nanometer-scale resolution, revealing details impossible to observe with conventional microscopy. This adaptation requires specific technical considerations:

• Fluorophore selection optimization:

  • Select fluorophores with appropriate photophysical properties for the specific super-resolution technique

  • For STORM/PALM: Use photoswitchable dyes (Alexa Fluor 647, Cy5) with high photon yield

  • For STED: Implement fluorophores with high depletion efficiency (ATTO 647N, Abberior STAR RED)

  • Consider conjugating direct fluorophores to primary antibody to minimize localization error

• Sample preparation refinement:

  • Implement thinner sectioning (50-100nm) for plant tissues to reduce out-of-focus background

  • Optimize fixation protocols to preserve nanoscale structures while maintaining epitope accessibility

  • Use specialized mounting media with matched refractive index and oxygen scavenging systems

  • Implement drift correction fiducials (gold nanoparticles) for extended acquisition

• Validation strategies:

  • Perform correlative light and electron microscopy to confirm nanoscale localization

  • Implement dual-color super-resolution with established organelle markers

  • Use quantitative analysis of clustering to assess biological significance of observed patterns

• Technical limitations consideration:

  • Account for the ~25nm localization uncertainty introduced by antibody size (primary + secondary)

  • Consider direct fusion of target protein with photoactivatable fluorescent proteins for highest precision

  • Implement controls with known spatial distributions to validate resolution capabilities

These adaptations enable researchers to visualize At3g61360 protein distribution at unprecedented resolution, revealing spatial relationships with interacting partners and subcellular structures not visible with conventional microscopy.

What approaches can researchers use to develop phospho-specific At3g61360 Antibodies for studying post-translational regulation?

Developing phospho-specific antibodies targeting At3g61360 protein requires specialized approaches to create reagents that selectively recognize specific phosphorylated residues. This advanced application enables the study of post-translational regulation through the following methodological framework:

• Phosphorylation site identification:

  • Analyze At3g61360 protein sequence using phosphorylation prediction algorithms

  • Confirm predicted sites through phosphoproteomics mass spectrometry

  • Prioritize evolutionarily conserved phosphorylation sites across related plant species

  • Focus on sites with known regulatory functions in homologous proteins

• Immunogen design strategy:

  • Synthesize phosphopeptides containing the target phosphorylated residue with 7-10 flanking amino acids

  • Include a C-terminal cysteine for carrier protein conjugation

  • Design both phosphorylated and non-phosphorylated peptides for subsequent purification steps

  • Consider multiple immunogen presentations (KLH, BSA, MAP conjugates) to enhance immune response

• Antibody production and purification workflow:

  • Immunize rabbits or other host species with phosphopeptide conjugates

  • Collect antisera and perform sequential affinity purification:
    a. Positive selection using phosphopeptide column
    b. Negative selection using non-phosphopeptide column to remove non-phospho-specific antibodies

  • Validate specificity using peptide competition assays with both phospho and non-phospho peptides

• Validation experimental design:

  • Test antibody reactivity with samples from wild-type versus phosphatase-treated extracts

  • Verify specificity with samples from plants treated with kinase activators/inhibitors

  • Use mutagenesis approaches (phospho-mimetic and phospho-dead mutations) for validation

  • Implement quantitative Western blot to assess the dynamic range of phospho-detection

This systematic approach yields phospho-specific antibodies that enable researchers to study the dynamic regulation of At3g61360 protein under different environmental conditions, developmental stages, or stress responses.

How can At3g61360 Antibody be integrated with CRISPR/Cas9 gene editing approaches for comprehensive protein function studies?

Integrating antibody-based detection with CRISPR/Cas9 gene editing creates a powerful system for comprehensive functional analysis of At3g61360 protein. This integrated approach leverages the strengths of both technologies through these methodological strategies:

• Antibody validation in CRISPR/Cas9 edited lines:

  • Generate complete knockout lines to serve as negative controls for antibody specificity

  • Create epitope-modified variants to map the precise antibody binding region

  • Develop lines with truncated protein variants to study domain-specific functions

  • Implement conditional knockout systems to study temporal aspects of protein function

• Tagged variant generation strategies:

  • Use CRISPR/Cas9 to insert epitope tags (HA, FLAG, V5) at the endogenous locus

  • Create fluorescent protein fusions while maintaining native regulatory elements

  • Implement split-protein complementation systems for interaction studies

  • Design degron-tagged variants for inducible protein degradation studies

• Functional domain analysis framework:

  • Generate systematic domain deletion variants

  • Create targeted amino acid substitutions at predicted functional sites

  • Assess protein-protein interaction patterns across variant libraries

  • Correlate structural modifications with phenotypic outcomes

• Quantitative phenotypic analysis pipeline:

  • Implement high-throughput phenotyping of mutant variants

  • Correlate protein expression levels (antibody-based quantification) with phenotypic severity

  • Analyze dose-dependent effects through heterozygous and homozygous comparison

  • Assess protein localization changes in response to environmental triggers

This integrated approach provides unprecedented insights into At3g61360 protein function by connecting precise genetic modifications with protein expression, localization, interaction, and phenotypic outcomes, establishing a comprehensive understanding of this protein's role in Arabidopsis biology.